Generation of Genetically Modified Rats Using CRISPR/Cas9 Genome-Editing System to Reveal Novel Vitamin D Actions

    January 2021 in “ Medical Research Archives
    Miyu Nishikawa, Kaori Yasuda, Hiroki Mano, Shinichi Ikushiro, Toshiyuki Sakaki
    New to Vitamin D? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study observed that 25-hydroxyvitamin D3 restored rickets symptoms in genetically modified rats, suggesting its direct action through vitamin D receptor pathways. Our plain-language summary of this paper — not a Tressless recommendation.
    The study utilized genetically modified rats to explore the molecular mechanisms of vitamin D action, focusing on the roles of 25-hydroxyvitamin D3 (25(OH)D3) and the vitamin D receptor (VDR). Researchers generated Cyp27b1-knockout (KO), Vdr-KO, and Vdr (R270L) rats, which exhibited symptoms of rickets, such as growth retardation and abnormal bone formation. Notably, Vdr-KO rats also showed abnormal skin formation and alopecia. Administration of 25(OH)D3 alleviated rickets symptoms in Cyp27b1-KO and Vdr (R270L) rats, indicating a direct action of 25(OH)D3 via VDR-genomic pathways. The study concluded that this novel in vivo system is valuable for understanding vitamin D's molecular mechanisms.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results